Miyajima K, Nekado T, Ikeda K, Achiwa K
School of Pharmaceutical Sciences, University of Schizuoka, Japan.
Chem Pharm Bull (Tokyo). 1998 Nov;46(11):1676-82. doi: 10.1248/cpb.46.1676.
Conjugates (3-5) of Tn, sialyl Tn and HIV-1-derived peptide antigen with a N-tetradecanoyl L-serine-beta-alanine-containing D-glucosamine derivative, structurally related to lipid A, as an immunoadjuvant for the development of totally synthetic vaccines against cancers or HIV were synthesized. The mitogenic activity of compounds 3, 4 and 5 was stronger than that of lipid A analogs (1, 2).
合成了Tn、唾液酸Tn和HIV-1衍生肽抗原与一种含N-十四烷酰-L-丝氨酸-β-丙氨酸的D-葡糖胺衍生物(其结构与脂多糖A相关)的缀合物(3-5),用作开发针对癌症或HIV的全合成疫苗的免疫佐剂。化合物3、4和5的促有丝分裂活性强于脂多糖A类似物(1、2)。